Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
GenomOncologygenomoncology.comGenomOncology offers the Precision Oncology Platform (POP), an end-to-end software suite that integrates fragmented data from EHRs, labs, and trials to deliver real-time, explainable decision support for oncology. The platform includes molecular pathology reporting, clinical trial optimization, data enablement, insights and analytics, and pathology decision support, designed to be configurable and adaptable to institutional workflows. They position themselves as a trusted partner to accelerate trial enrollment, streamline reporting, and improve patient care for oncologists, pathologists, lab directors and researchers at leading healthcare institutions.
Sources
youtube.com shapes more of what AI says about GenomOncology than any other source, at 69% of its citations.
appliedclinicaltrialsonline.com · genomoncology.com · parse.gl
The market map
Clinical Trial Feasibility Software →Where AI ranks GenomOncology
Excerpts where GenomOncology appeared in the AI's answer
GenomOncology - Uses a precision oncology knowledge graph and symbolic AI/LLMs to codify molecular biomarkers and clinical trial criteria, reducing false-positive matches for clinical trial navigators
GenomOncology : Utilizes a precision oncology knowledge graph and AI tools
